Matthew Vincent Dolan, SVP Corporate Development at DEXCOM INC (DXCM), sold 3,202 shares at $425.00 ($1.3M) on 2022-03-16, disclosed to the SEC on 2022-03-17.
Open-market sale of $1.3M DXCM by SVP Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $412.41 | 1,016 | $419K | 31.1% |
| 2 | $412.41 | 1,016 | $419K | 31.1% |
| 3 | $425.00 | 686 | $292K | 21.6% |
| 4 | $450.00 | 484 | $218K | 16.2% |
| Total | $420.79 avg | 3,202 | $1.3M | 100% |
| Filing → |
| DXCM | SELL | 2024-04-16 | $548K | — | Filing → |
| DXCM | SELL | 2024-03-19 | $1.1M | — | Filing → |
| DXCM | SELL | 2024-03-14 | $1.8M | — | Filing → |